Review




Structured Review

Galectin Therapeutics galectin-3 inhibitor modified citrus pectin
Galectin 3 Inhibitor Modified Citrus Pectin, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-3+inhibitor+modified+citrus+pectin/galectin+3/pmc07838053__mmc1-82-3-3
Average 90 stars, based on 1 article reviews
galectin-3 inhibitor modified citrus pectin - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

Modification:

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates neuroinflammation in T2DM rats.

Article Title: Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension
Article Snippet: Randomized trial of galectin-3 inhibitor modified citrus pectin (MCP) vs placebo A total of 68 participants met enrollment criteria and were randomized to the Gal-3 inhibitor MCP vs matching placebo for a total duration of 6 months.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Figure 2 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves cognitive function in T2DM rats.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates inflammation in high glucose (HG)-stimulated BV-2 cells.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves insulin sensitivity in T2DM rats.

Article Title: <p>Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro</p>
Article Snippet: Gal3 Inhibition Alleviates High Glucose (HG)-Induced Damage to BV-2 Cells BV-2 cells were exposed to increasing concentrations of glucose (50, 100, or 200 mmol/L) for 48 h to establish the concentration of glucose that induced cell death, and Figure 2 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves cognitive function in T2DM rats.

Article Title: <p>Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro</p>
Article Snippet: Figure 5 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates inflammation in high glucose (HG)-stimulated BV-2 cells.

Control:

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates neuroinflammation in T2DM rats.

Article Title: Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension
Article Snippet: Randomized trial of galectin-3 inhibitor modified citrus pectin (MCP) vs placebo A total of 68 participants met enrollment criteria and were randomized to the Gal-3 inhibitor MCP vs matching placebo for a total duration of 6 months.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Figure 2 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves cognitive function in T2DM rats.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates inflammation in high glucose (HG)-stimulated BV-2 cells.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves insulin sensitivity in T2DM rats.

Article Title: <p>Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro</p>
Article Snippet: Gal3 Inhibition Alleviates High Glucose (HG)-Induced Damage to BV-2 Cells BV-2 cells were exposed to increasing concentrations of glucose (50, 100, or 200 mmol/L) for 48 h to establish the concentration of glucose that induced cell death, and Figure 2 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves cognitive function in T2DM rats.

Article Title: <p>Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro</p>
Article Snippet: Figure 5 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates inflammation in high glucose (HG)-stimulated BV-2 cells.

Activity Assay:

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates neuroinflammation in T2DM rats.

Article Title: Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension
Article Snippet: Randomized trial of galectin-3 inhibitor modified citrus pectin (MCP) vs placebo A total of 68 participants met enrollment criteria and were randomized to the Gal-3 inhibitor MCP vs matching placebo for a total duration of 6 months.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Figure 2 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves cognitive function in T2DM rats.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates inflammation in high glucose (HG)-stimulated BV-2 cells.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves insulin sensitivity in T2DM rats.

Article Title: <p>Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro</p>
Article Snippet: Gal3 Inhibition Alleviates High Glucose (HG)-Induced Damage to BV-2 Cells BV-2 cells were exposed to increasing concentrations of glucose (50, 100, or 200 mmol/L) for 48 h to establish the concentration of glucose that induced cell death, and Figure 2 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves cognitive function in T2DM rats.

Article Title: <p>Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro</p>
Article Snippet: Figure 5 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates inflammation in high glucose (HG)-stimulated BV-2 cells.

MTT Assay:

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates neuroinflammation in T2DM rats.

Article Title: Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension
Article Snippet: Randomized trial of galectin-3 inhibitor modified citrus pectin (MCP) vs placebo A total of 68 participants met enrollment criteria and were randomized to the Gal-3 inhibitor MCP vs matching placebo for a total duration of 6 months.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Figure 2 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves cognitive function in T2DM rats.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates inflammation in high glucose (HG)-stimulated BV-2 cells.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves insulin sensitivity in T2DM rats.

Article Title: <p>Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro</p>
Article Snippet: Gal3 Inhibition Alleviates High Glucose (HG)-Induced Damage to BV-2 Cells BV-2 cells were exposed to increasing concentrations of glucose (50, 100, or 200 mmol/L) for 48 h to establish the concentration of glucose that induced cell death, and Figure 2 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves cognitive function in T2DM rats.

Article Title: <p>Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro</p>
Article Snippet: Figure 5 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates inflammation in high glucose (HG)-stimulated BV-2 cells.

Inhibition:

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates neuroinflammation in T2DM rats.

Article Title: Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension
Article Snippet: Randomized trial of galectin-3 inhibitor modified citrus pectin (MCP) vs placebo A total of 68 participants met enrollment criteria and were randomized to the Gal-3 inhibitor MCP vs matching placebo for a total duration of 6 months.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Figure 2 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves cognitive function in T2DM rats.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates inflammation in high glucose (HG)-stimulated BV-2 cells.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves insulin sensitivity in T2DM rats.

Article Title: <p>Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro</p>
Article Snippet: Gal3 Inhibition Alleviates High Glucose (HG)-Induced Damage to BV-2 Cells BV-2 cells were exposed to increasing concentrations of glucose (50, 100, or 200 mmol/L) for 48 h to establish the concentration of glucose that induced cell death, and Figure 2 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves cognitive function in T2DM rats.

Article Title: <p>Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro</p>
Article Snippet: Figure 5 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates inflammation in high glucose (HG)-stimulated BV-2 cells.

Concentration Assay:

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates neuroinflammation in T2DM rats.

Article Title: Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension
Article Snippet: Randomized trial of galectin-3 inhibitor modified citrus pectin (MCP) vs placebo A total of 68 participants met enrollment criteria and were randomized to the Gal-3 inhibitor MCP vs matching placebo for a total duration of 6 months.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Figure 2 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves cognitive function in T2DM rats.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates inflammation in high glucose (HG)-stimulated BV-2 cells.

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
Article Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves insulin sensitivity in T2DM rats.

Article Title: <p>Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro</p>
Article Snippet: Gal3 Inhibition Alleviates High Glucose (HG)-Induced Damage to BV-2 Cells BV-2 cells were exposed to increasing concentrations of glucose (50, 100, or 200 mmol/L) for 48 h to establish the concentration of glucose that induced cell death, and Figure 2 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves cognitive function in T2DM rats.

Article Title: <p>Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro</p>
Article Snippet: Figure 5 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates inflammation in high glucose (HG)-stimulated BV-2 cells.



Similar Products

90
Galectin Therapeutics galectin-3 inhibitor modified citrus pectin
Galectin 3 Inhibitor Modified Citrus Pectin, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-3+inhibitor+modified+citrus+pectin/galectin+3/pmc07838053__mmc1-82-3-3
Average 90 stars, based on 1 article reviews
galectin-3 inhibitor modified citrus pectin - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Galectin Therapeutics galectin-3 inhibitor modified citrus pectin (mcp)
Galectin-3 <t>(Gal3)</t> inhibitor modified citrus pectin (MCP) improves insulin sensitivity in T2DM rats. Notes: Effects of MCP on the levels of FBG ( A ), FINS ( B ), HOMA-IR ( C ), and serum Gal3 ( D ) in T2DM rats. The data are from three independent experiments. a P <0.05, b P <0.01 compared to the control rats; c P <0.05, d P <0.01 compared to the T2DM rats. Abbreviations: T2DM, type 2 diabetes mellitus; MCP, modified citrus pectin; FBG, fasting blood glucose; FINS, fasting insulin; HOMA-IR, homeostasis model assessment of insulin resistance.
Galectin 3 Inhibitor Modified Citrus Pectin (Mcp), supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-3+inhibitor+modified+citrus+pectin/galectin+3+inhibitor+modified+citrus+pectin/pmc07508034-109-2-2
Average 90 stars, based on 1 article reviews
galectin-3 inhibitor modified citrus pectin (mcp) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves insulin sensitivity in T2DM rats. Notes: Effects of MCP on the levels of FBG ( A ), FINS ( B ), HOMA-IR ( C ), and serum Gal3 ( D ) in T2DM rats. The data are from three independent experiments. a P <0.05, b P <0.01 compared to the control rats; c P <0.05, d P <0.01 compared to the T2DM rats. Abbreviations: T2DM, type 2 diabetes mellitus; MCP, modified citrus pectin; FBG, fasting blood glucose; FINS, fasting insulin; HOMA-IR, homeostasis model assessment of insulin resistance.

Journal: Journal of Inflammation Research

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro

doi: 10.2147/JIR.S273858

Figure Lengend Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves insulin sensitivity in T2DM rats. Notes: Effects of MCP on the levels of FBG ( A ), FINS ( B ), HOMA-IR ( C ), and serum Gal3 ( D ) in T2DM rats. The data are from three independent experiments. a P <0.05, b P <0.01 compared to the control rats; c P <0.05, d P <0.01 compared to the T2DM rats. Abbreviations: T2DM, type 2 diabetes mellitus; MCP, modified citrus pectin; FBG, fasting blood glucose; FINS, fasting insulin; HOMA-IR, homeostasis model assessment of insulin resistance.

Article Snippet: Figure 4 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves the viability of BV-2 microglial cells.

Techniques: Modification, Control

Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves cognitive function in T2DM rats. Notes: ( A ) No significant differences were found in escape latency during the 2-day visible platform test. ( B ) Changes in escape latency during the 3-day invisible platform test. a P <0.05, b P <0.01 compared to the control rats; c P <0.05, d P <0.01 compared to the T2DM rats. Abbreviations: T2DM, type 2 diabetes mellitus; MCP, modified citrus pectin.

Journal: Journal of Inflammation Research

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro

doi: 10.2147/JIR.S273858

Figure Lengend Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves cognitive function in T2DM rats. Notes: ( A ) No significant differences were found in escape latency during the 2-day visible platform test. ( B ) Changes in escape latency during the 3-day invisible platform test. a P <0.05, b P <0.01 compared to the control rats; c P <0.05, d P <0.01 compared to the T2DM rats. Abbreviations: T2DM, type 2 diabetes mellitus; MCP, modified citrus pectin.

Article Snippet: Figure 4 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves the viability of BV-2 microglial cells.

Techniques: Modification, Control

Effects of  Galectin-3   (Gal3)  Inhibitor MCP on ROS Level, MDA and Protein Carbonyl Contents, and Antioxidant Enzymes Catalase in Hippocampus and Cerebral Cortex of HFD/STZ-Induced T2DM Rats

Journal: Journal of Inflammation Research

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro

doi: 10.2147/JIR.S273858

Figure Lengend Snippet: Effects of Galectin-3 (Gal3) Inhibitor MCP on ROS Level, MDA and Protein Carbonyl Contents, and Antioxidant Enzymes Catalase in Hippocampus and Cerebral Cortex of HFD/STZ-Induced T2DM Rats

Article Snippet: Figure 4 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves the viability of BV-2 microglial cells.

Techniques: Activity Assay, Control

Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates neuroinflammation in T2DM rats. Notes: MCP decreases the levels of IL-1β ( A ), IL-6 ( B ), and TNF-α ( C ) in the hippocampus and cerebral cortex in T2DM rats. a P <0.05, b P <0.01 compared to the control rats; c P <0.05, d P <0.01 compared to the T2DM rats. Abbreviations: T2DM, type 2 diabetes mellitus; MCP, modified citrus pectin; IL-1β, interleukin-1β; IL-6, interleukin-6; TNF-α, tumor necrosis factor-alpha.

Journal: Journal of Inflammation Research

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro

doi: 10.2147/JIR.S273858

Figure Lengend Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates neuroinflammation in T2DM rats. Notes: MCP decreases the levels of IL-1β ( A ), IL-6 ( B ), and TNF-α ( C ) in the hippocampus and cerebral cortex in T2DM rats. a P <0.05, b P <0.01 compared to the control rats; c P <0.05, d P <0.01 compared to the T2DM rats. Abbreviations: T2DM, type 2 diabetes mellitus; MCP, modified citrus pectin; IL-1β, interleukin-1β; IL-6, interleukin-6; TNF-α, tumor necrosis factor-alpha.

Article Snippet: Figure 4 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves the viability of BV-2 microglial cells.

Techniques: Modification, Control

Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves the viability of BV-2 microglial cells. Notes: ( A ) The effects of different concentrations of glucose and mannitol on BV-2 cells. ( B ) Effects of the Gal3 inhibitor MCP on HG-stimulated BV-2 cells. The MTT assay was used to measure cell viability. The ratio of the OD value of each group to that of the control group was calculated as the cell viability. a P <0.05, b P <0.01 compared to the control cells; c P <0.05, d P <0.01 compared to the HG-stimulated cells. Abbreviations: MCP, modified citrus pectin; HG, high glucose.

Journal: Journal of Inflammation Research

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro

doi: 10.2147/JIR.S273858

Figure Lengend Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves the viability of BV-2 microglial cells. Notes: ( A ) The effects of different concentrations of glucose and mannitol on BV-2 cells. ( B ) Effects of the Gal3 inhibitor MCP on HG-stimulated BV-2 cells. The MTT assay was used to measure cell viability. The ratio of the OD value of each group to that of the control group was calculated as the cell viability. a P <0.05, b P <0.01 compared to the control cells; c P <0.05, d P <0.01 compared to the HG-stimulated cells. Abbreviations: MCP, modified citrus pectin; HG, high glucose.

Article Snippet: Figure 4 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves the viability of BV-2 microglial cells.

Techniques: Modification, MTT Assay, Control

Effects of  Galectin-3   (Gal3)  Inhibitor MCP on ROS Level, MDA and Protein Carbonyl Contents, and Antioxidant Enzymes Catalase in High Glucose Exposed BV-2 Microglial Cells

Journal: Journal of Inflammation Research

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro

doi: 10.2147/JIR.S273858

Figure Lengend Snippet: Effects of Galectin-3 (Gal3) Inhibitor MCP on ROS Level, MDA and Protein Carbonyl Contents, and Antioxidant Enzymes Catalase in High Glucose Exposed BV-2 Microglial Cells

Article Snippet: Figure 4 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves the viability of BV-2 microglial cells.

Techniques: Activity Assay, Control

Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates inflammation in high glucose (HG)-stimulated BV-2 cells. Notes: The BV-2 cells were pretreated with 0.01% MCP for 24 h before being treated with 100 mM glucose for 24 h. The levels of IL-1β ( A ), IL-6 ( B ), and TNF-α ( C ) in the cell supernatant were measured. a P <0.05, b P <0.01 compared to the control cells; c P <0.05, d P <0.01 compared to the HG-stimulated cells. Abbreviations: MCP, modified citrus pectin; IL-1β, interleukin-1β; IL-6, interleukin-6; TNF-α, tumor necrosis factor-alpha; HG, high glucose.

Journal: Journal of Inflammation Research

Article Title: Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro

doi: 10.2147/JIR.S273858

Figure Lengend Snippet: Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) attenuates inflammation in high glucose (HG)-stimulated BV-2 cells. Notes: The BV-2 cells were pretreated with 0.01% MCP for 24 h before being treated with 100 mM glucose for 24 h. The levels of IL-1β ( A ), IL-6 ( B ), and TNF-α ( C ) in the cell supernatant were measured. a P <0.05, b P <0.01 compared to the control cells; c P <0.05, d P <0.01 compared to the HG-stimulated cells. Abbreviations: MCP, modified citrus pectin; IL-1β, interleukin-1β; IL-6, interleukin-6; TNF-α, tumor necrosis factor-alpha; HG, high glucose.

Article Snippet: Figure 4 Galectin-3 (Gal3) inhibitor modified citrus pectin (MCP) improves the viability of BV-2 microglial cells.

Techniques: Modification, Control